I made yet another shares purchase today and this time round, the company picked was C&O Pharmaceutical Technology Limited [E92.SI].
The main reason why I bought this C&O is due to impressive to-come dividends. As anticipated by Philip Research, 4Q dividend could be at S$0.012 which makes the whole year dividend to be at S$0.08. If we were to use today's S$0.47/share, it would be 17%! This very healthy net cash comes after they sold Hong kong asset, which add to their EPS.
1 past dividend and 1 coming soon
Ex Date: 26 Aug 2010 SGD 0.028
Ex Date: 12 Jul 2010 SGD 0.005
Ex Date: 12 Jul 2010 SGD 0.035
This China-based drug maker's strong R&D capability provides springboard to launch new products, paving way for expansion in local and international markets. According to CIMB analyst, C&O is also an attractive partner to foreign drug companies looking to enter the China market.
Stay invested for the dividends remain my key investment strategy.
Computer, Technology, Databases, Google, Internet, Mobile, Linux, Microsoft, Open Source, Security, Social Media, Web Development, Business, Finance
Subscribe to:
Post Comments (Atom)
-
Google url shortener service, goo.gl , is now much improved with newly included features like easier copy and paste, and ability to delete e...
-
According to an article from the MSDN , DirectoryInfo.GetFiles() method will give unexpected behaviour on 3-letter extensions. I quote Micr...
-
Installed FortiClient recently but the challenge in disabling the application/service from running automatically on every start-up annoyed m...
-
ActiveSG is a national initiative from the Singapore government to encourage all to stay healthy and keeping fit. Membership registration i...
No comments:
Post a Comment
Do provide your constructive comment. I appreciate that.